查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1773770

電生理消融市場：全球產業分析、市場規模、佔有率、成長、趨勢與預測（2025-2032）

Electrophysiology Ablation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 220 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球電生理消融市場的全面分析報告。本報告對重要市場動態進行了全面評估，包括市場促進因素、趨勢、機會和挑戰，並深入分析了市場結構。報告提供了獨家資料和統計資料，概述了全球電生理消融市場的預測成長軌跡（2025-2032年）。

關鍵見解

  • 電生理消融市場規模（2025年）：38.471億美元
  • 市場規模預測（以金額為準，2032年）：69.428億美元
  • 全球市場成長率（2025-2032年年複合成長率）：8.8%

電生理消融市場-分析範圍

電生理消融市場涵蓋各種醫療程序和設備，這些程序和設備透過靶向併中和心臟內異常電通路來治療心律不整。此程序廣泛應用於治療心房顫動、心房撲動和心室心搏過速等疾病。心律不整盛行率的不斷上升以及消融導管和影像系統的技術進步，推動全球對電生理消融的需求。由於其微創特性和高成功率，該市場的應用也日益廣泛。

市場成長動力：

心血管疾病（尤其是心房顫動和其他心律不整）日益加重的負擔是推動電生理消融市場發展的主要因素。人們對早期診斷和治療的認知不斷提高，以及易患心臟病的老年人口增加，都大幅促進了市場的擴張。此外，接觸力感測導管和機器人導航系統等消融技術的不斷進步，提高手術的準確性和治療效果。已開發經濟體和新興經濟體的政府扶持政策和醫療保健支出也促進了市場的發展。

市場限制：

儘管成長條件良好，電生理消融市場仍面臨許多限制因素。一些國家高昂的手術費用和嚴格的償付政策可能會限制患者，尤其是在低收入地區，獲得該服務的機會。此外，消融手術的複雜性需要經驗豐富的電生理學家，而訓練有素的專業人員的短缺可能會阻礙該手術的推廣。儘管心臟穿孔和中風等併發症很少見，但人們對此的擔憂也可能成為阻礙力。此外，新技術冗長的核准流程可能會延遲創新設備的市場准入。

市場機會：

透過整合人工智慧和3D映射技術，在改善電生理消融術的程序規劃和即時監控方面蘊藏著巨大的機會。印度、中國和巴西等新興國家醫療基礎設施的快速擴張，帶來了巨大的市場潛力。門診手術中心和專科心臟科中心的門診電生理手術日益增多，也創造了新的成長潛力。此外，醫療科技公司與醫院在臨床試驗和設備開發方面的合作，為更有效率、更安全的消融技術以及更短的恢復時間鋪平道路。

本報告回答的關鍵問題

  • 推動全球電生理消融市場成長的主要因素有哪些？
  • 哪些地區和應用消融技術的需求最高？
  • 消融技術的創新如何影響治療結果和病人安全？
  • 電生理消融市場的主要企業有哪些？他們的戰略重點是什麼？
  • 全球電生理消融市場的新興趨勢和長期預測是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
    • 課題
    • 主要趨勢
  • COVID-19影響分析
  • 預測因子：相關性和影響力

第3章 加值分析

  • 價值鏈分析
  • 產品採用/使用分析
  • 主要市場參與者
  • 主要參與者的主要促銷策略
  • 監管狀況
  • PESTLE分析
  • 波特五力分析

第4章 全球電生理消融市場展望

  • 主要亮點
    • 市場規模及年成長率（以金額為準）
    • 絕對的商機
  • 市場規模分析與預測（以金額為準）
    • 歷史市場規模分析（以金額為準，2019-2024）
    • 當前市場規模分析與預測（以金額為準，2025-2032）
  • 全球電生理消融市場展望：依產品
    • 引言/主要發現
    • 歷史市場規模分析：依產品（以金額為準，2019-2024年）
    • 當前市場規模分析：依產品（以金額為準，2025-2032年）
      • 診斷導管
      • 消融導管
      • 存取裝置
    • 市場吸引力分析：依產品
  • 全球電生理消融市場展望：依應用
    • 引言/主要發現
    • 歷史市場規模分析：依應用（以金額為準，2019-2024）
    • 目前市場規模分析：依應用（以金額為準，2025-2032）
      • 心室上性心搏過速（SVT）消融
      • 心室心搏過速（VT/VPC）
      • 心房顫動（AF）
      • 心房撲動
      • 其他
    • 市場吸引力分析：依應用
  • 全球電生理消融市場前景：依最終用戶
    • 引言/主要發現
    • 歷史市場規模分析：依最終用戶（以金額為準，2019-2024年）
    • 當前市場規模分析：依最終用戶（以金額為準，2025-2032）
      • 醫院
      • 門診手術中心
      • 專門心臟中心
      • 診所
    • 市場吸引力分析：依最終用戶

第5章 全球電生理消融市場展望：依地區

  • 主要亮點
  • 歷史市場規模分析：依地區（以金額為準，2019-2024年）
  • 目前市場規模預測：依地區（以金額為準，2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：依地區

第6章 北美電生理消融市場展望

第7章 歐洲電生理消融市場展望

第8章 東亞電生理消融市場展望

第9章 南亞與大洋洲電生理消融市場展望

第10章 拉丁美洲電生理消融市場展望

第11章 中東和非洲電生理消融市場展望

第12章 競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競爭強度圖：依市場
    • 競爭儀錶板
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Biosense Webster
    • Abbott Laboratories
    • MEDTRONIC PLC
    • Boston Scientific Corporation
    • CathRx Ltd
    • Biotronik SE &Co. KG.
    • Japan Lifeline Co
    • ATRICURE, INC.
    • Auris Health
    • Biomerics.
    • Others

第13章 附錄

  • 分析方法
  • 分析假設
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP25474

Persistence Market Research has recently released a comprehensive report on the global Electrophysiology Ablation Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Electrophysiology Ablation Market Size (2025E): US$ 3,847.1 Mn
  • Projected Market Value (2032F): US$ 6,942.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.8%

Electrophysiology Ablation Market - Report Scope:

The electrophysiology ablation market comprises medical procedures and devices used to treat abnormal heart rhythms by targeting and neutralizing faulty electrical pathways in the heart. The procedure is widely used in managing conditions such as atrial fibrillation, atrial flutter, and ventricular tachycardia. Increasing prevalence of cardiac arrhythmias, coupled with technological innovations in ablation catheters and imaging systems, are driving the demand for electrophysiology ablation worldwide. The market is also witnessing growing adoption due to its minimally invasive nature and higher success rates.

Market Growth Drivers:

The growing burden of cardiovascular diseases, particularly atrial fibrillation and other arrhythmias, is a major factor propelling the electrophysiology ablation market. Increased awareness of early diagnosis and treatment, along with the rising geriatric population prone to heart conditions, is contributing significantly to market expansion. Moreover, continuous advancements in ablation technologies, such as contact force-sensing catheters and robotic navigation systems, are enhancing procedural accuracy and outcomes. Supportive government initiatives and healthcare spending in both developed and developing nations are also strengthening market growth.

Market Restraints:

Despite favorable growth conditions, the electrophysiology ablation market faces several constraints. High procedural costs and limited reimbursement policies in some countries may restrict patient access, especially in low-income regions. Additionally, the complexity of ablation procedures requires skilled electrophysiologists, and a shortage of trained professionals can hinder procedural adoption. Concerns related to complications such as cardiac perforation or stroke, though rare, may also act as deterrents. Furthermore, long regulatory approval processes for new technologies can delay market entry for innovative devices.

Market Opportunities:

Significant opportunities lie in the integration of artificial intelligence and 3D mapping technologies to improve procedure planning and real-time monitoring in electrophysiology ablation. Rapid expansion of healthcare infrastructure in emerging economies like India, China, and Brazil opens up vast market potential. The growing trend of outpatient electrophysiology procedures in ambulatory surgical centers and specialty cardiac centers also creates new growth avenues. Furthermore, collaborations between medtech firms and hospitals for clinical trials and device development are paving the way for more efficient, safer ablation techniques with shorter recovery times.

Key Questions Answered in the Report:

  • What are the primary factors driving the global electrophysiology ablation market's growth?
  • Which regions and application areas are witnessing the highest demand for ablation procedures?
  • How are innovations in ablation technology influencing treatment outcomes and patient safety?
  • Who are the leading players in the electrophysiology ablation market and what are their strategic priorities?
  • What are the emerging trends and long-term forecasts for the global electrophysiology ablation market?

Competitive Intelligence and Business Strategy:

Leading companies in the global electrophysiology ablation market, such as Biosense Webster, Abbott Laboratories, and Boston Scientific Corporation, are focusing heavily on R&D and product innovation to gain a competitive edge. These firms are developing advanced ablation systems with real-time imaging, improved energy delivery, and enhanced navigation capabilities. Strategic partnerships with hospitals, acquisitions, and global expansion efforts are helping key players consolidate their market position. Emphasis is also placed on physician training and education programs to promote technology adoption in emerging regions.

Companies Covered in This Report:

  • Biosense Webster
  • Abbott Laboratories
  • MEDTRONIC PLC
  • Boston Scientific Corporation
  • CathRx Ltd
  • Biotronik SE & Co. KG.
  • Japan Lifeline Co
  • ATRICURE, INC.
  • Auris Health
  • Biomerics
  • Others

Market Segmentation

By Product Type:

  • Diagnostic Catheter
  • Ablation Catheter
  • Access Device

By Application:

  • Supraventricular Tachycardia (SVT) Ablation
  • Ventricular Tachycardia (VT/VPC)
  • Atrial Fibrillation (AF)
  • Atrial Flutter
  • Others

By End-User:

  • Hospital
  • Ambulatory Surgical Centre
  • Specialty Cardiac Centers
  • Clinic

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Electrophysiology Ablation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Value Chain Analysis
  • 3.2. Product Adoption / Usage Analysis
  • 3.3. Key Market Players
  • 3.4. Key Promotional Strategies, By Key Players
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Electrophysiology Ablation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Electrophysiology Ablation Market Outlook: Product
    • 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
    • 4.3.2. Current Market Size (US$ Mn) Analysis, By Product, 2025-2032
      • 4.3.2.1. Diagnostic Catheter
      • 4.3.2.2. Ablation Catheter
      • 4.3.2.3. Access Device
    • 4.3.3. Market Attractiveness Analysis: Product
  • 4.4. Global Electrophysiology Ablation Market Outlook: Application
    • 4.4.1. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.2.1. Supraventricular tachycardia (SVT) ablation
      • 4.4.2.2. Ventricular tachycardia (VT/VPC)
      • 4.4.2.3. Atrial fibrillation (AF)
      • 4.4.2.4. Atrial flutter
      • 4.4.2.5. Others
    • 4.4.3. Market Attractiveness Analysis: Application
  • 4.5. Global Electrophysiology Ablation Market Outlook: End-User
    • 4.5.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2024
    • 4.5.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
      • 4.5.2.1. Hospital
      • 4.5.2.2. Ambulatory Surgical Centre
      • 4.5.2.3. Specialty Cardiac Centers
      • 4.5.2.4. Clinic
    • 4.5.3. Market Attractiveness Analysis: End-User

5. Global Electrophysiology Ablation Market Outlook: Region

  • 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.2. Current Market Size (US$ Mn) Analysis, by Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Latin America
    • 5.2.3. Europe
    • 5.2.4. East Asia
    • 5.2.5. South Asia and Oceania
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Electrophysiology Ablation Market Outlook

  • 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Product
    • 6.1.3. By Application
    • 6.1.4. By End-User
  • 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 6.3.1. Diagnostic Catheter
    • 6.3.2. Ablation Catheter
    • 6.3.3. Access Device
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 6.4.1. Supraventricular tachycardia (SVT) ablation
    • 6.4.2. Ventricular tachycardia (VT/VPC)
    • 6.4.3. Atrial fibrillation (AF)
    • 6.4.4. Atrial flutter
    • 6.4.5. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 6.5.1. Hospital
    • 6.5.2. Ambulatory Surgical Centre
    • 6.5.3. Specialty Cardiac Centers
    • 6.5.4. Clinic
  • 6.6. Market Attractiveness Analysis

7. Europe Electrophysiology Ablation Market Outlook

  • 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Product
    • 7.1.3. By Application
    • 7.1.4. By End-User
  • 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 7.3.1. Diagnostic Catheter
    • 7.3.2. Ablation Catheter
    • 7.3.3. Access Device
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.4.1. Supraventricular tachycardia (SVT) ablation
    • 7.4.2. Ventricular tachycardia (VT/VPC)
    • 7.4.3. Atrial fibrillation (AF)
    • 7.4.4. Atrial flutter
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 7.5.1. Hospital
    • 7.5.2. Ambulatory Surgical Centre
    • 7.5.3. Specialty Cardiac Centers
    • 7.5.4. Clinic
  • 7.6. Market Attractiveness Analysis

8. East Asia Electrophysiology Ablation Market Outlook

  • 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Product
    • 8.1.3. By Application
    • 8.1.4. By End-User
  • 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 8.3.1. Diagnostic Catheter
    • 8.3.2. Ablation Catheter
    • 8.3.3. Access Device
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.4.1. Supraventricular tachycardia (SVT) ablation
    • 8.4.2. Ventricular tachycardia (VT/VPC)
    • 8.4.3. Atrial fibrillation (AF)
    • 8.4.4. Atrial flutter
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 8.5.1. Hospital
    • 8.5.2. Ambulatory Surgical Centre
    • 8.5.3. Specialty Cardiac Centers
    • 8.5.4. Clinic
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Electrophysiology Ablation Market Outlook

  • 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Product
    • 9.1.3. By Application
    • 9.1.4. By End-User
  • 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Indonesia
    • 9.2.3. Thailand
    • 9.2.4. Singapore
    • 9.2.5. ANZ
    • 9.2.6. Rest of South Asia & Oceania
  • 9.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 9.3.1. Diagnostic Catheter
    • 9.3.2. Ablation Catheter
    • 9.3.3. Access Device
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.4.1. Supraventricular tachycardia (SVT) ablation
    • 9.4.2. Ventricular tachycardia (VT/VPC)
    • 9.4.3. Atrial fibrillation (AF)
    • 9.4.4. Atrial flutter
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 9.5.1. Hospital
    • 9.5.2. Ambulatory Surgical Centre
    • 9.5.3. Specialty Cardiac Centers
    • 9.5.4. Clinic
  • 9.6. Market Attractiveness Analysis

10. Latin America Electrophysiology Ablation Market Outlook

  • 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Product
    • 10.1.3. By Application
    • 10.1.4. By End-User
  • 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 10.3.1. Diagnostic Catheter
    • 10.3.2. Ablation Catheter
    • 10.3.3. Access Device
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.4.1. Supraventricular tachycardia (SVT) ablation
    • 10.4.2. Ventricular tachycardia (VT/VPC)
    • 10.4.3. Atrial fibrillation (AF)
    • 10.4.4. Atrial flutter
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 10.5.1. Hospital
    • 10.5.2. Ambulatory Surgical Centre
    • 10.5.3. Specialty Cardiac Centers
    • 10.5.4. Clinic
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Electrophysiology Ablation Market Outlook

  • 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Product
    • 11.1.3. By Application
    • 11.1.4. By End-User
  • 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 11.3.1. Diagnostic Catheter
    • 11.3.2. Ablation Catheter
    • 11.3.3. Access Device
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.4.1. Supraventricular tachycardia (SVT) ablation
    • 11.4.2. Ventricular tachycardia (VT/VPC)
    • 11.4.3. Atrial fibrillation (AF)
    • 11.4.4. Atrial flutter
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 11.5.1. Hospital
    • 11.5.2. Ambulatory Surgical Centre
    • 11.5.3. Specialty Cardiac Centers
    • 11.5.4. Clinic
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Biosense Webster
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Sources
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abbott Laboratories
    • 12.3.3. MEDTRONIC PLC
    • 12.3.4. Boston Scientific Corporation
    • 12.3.5. CathRx Ltd
    • 12.3.6. Biotronik SE & Co. KG.
    • 12.3.7. Japan Lifeline Co
    • 12.3.8. ATRICURE, INC.
    • 12.3.9. Auris Health
    • 12.3.10. Biomerics.
    • 12.3.11. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations